![Matthew Wiley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Wiley
Corporate Officer/Principal bei
DEFINIUM THERAPEUTICS, INC.
Vermögen: 14 Mio $ am 31.08.2026
Profil
Matthew T.
Wiley is Chief Commercial Officer at Definium Therapeutics, Inc. since 2025.
Former roles include Chief Commercial Officer & Senior Vice President at BioXcel Therapeutics, Inc. from 2022 to 2024; Chief Commercial Officer at VYNE Pharmaceuticals Ltd. from 2018 to 2020; Vice President-Marketing at Jazz Pharmaceuticals, Inc. from 2012 to 2018; Vice President-Marketing at Jazz Pharmaceuticals Commercial Corp.
from 2007 to 2012; and Chief Commercial Officer at Menlo Therapeutics, Inc. Education includes undergraduate studies at Syracuse University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 25.09.2026 | 359 036 ( 0,27 % ) | 14 Mio $ | 31.08.2026 |
Aktive Positionen von Matthew Wiley
| Unternehmen | Position | Beginn |
|---|---|---|
| DEFINIUM THERAPEUTICS, INC. | Corporate Officer/Principal | 17.03.2025 |
Ehemalige bekannte Positionen von Matthew Wiley
| Unternehmen | Position | Ende |
|---|---|---|
| BIOXCEL THERAPEUTICS, INC. | Corporate Officer/Principal | 02.10.2024 |
VYNE Pharmaceuticals Ltd.
 VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for dermatology, gynecology, wounds and burns and ophthalmic disorders | Corporate Officer/Principal | 09.03.2020 |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Vertrieb & Marketing | 01.01.2018 |
Jazz Pharmaceuticals Commercial Corp.
 Jazz Pharmaceuticals Commercial Corp. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical services | Vertrieb & Marketing | 01.01.2012 |
Jazz Pharmaceuticals Commercial Corp.
Jazz Pharmaceuticals Commercial Corp. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical services | Vertrieb & Marketing | - |
Ausbildung von Matthew Wiley
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
62
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for dermatology, gynecology, wounds and burns and ophthalmic disorders | Health Technology |
Menlo Therapeutics, Inc.
 Menlo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of serlopitant products | Health Technology |
Syracuse University
 Syracuse University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jazz Pharmaceuticals Commercial Corp.
Jazz Pharmaceuticals Commercial Corp. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical services | Health Technology |
BioXcel Therapeutics, Inc.
 BioXcel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops transformative medicines in neuroscience and immuno-oncology | Health Technology |
Mind Medicine (MindMed), Inc.
 Mind Medicine (MindMed), Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical biopharmaceutical company which develops novel products to treat brain health disorders | Health Technology |
VYNE Therapeutics, Inc.
 VYNE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
